PEREGO, PAOLA
PEREGO, PAOLA
Universita' degli Studi di MILANO
Curcumin and Related Compounds in Cancer Cells: New Avenues for Old Molecules
2022 M. Costantino, C. Corno, D. Colombo, P. Perego
Targeting of the Lipid Metabolism Impairs Resistance to BRAF Kinase Inhibitor in Melanoma
2022 E. Vergani, G.L. Beretta, M. Aloisi, M. Costantino, C. Corno, S. Frigerio, S. Tinelli, M. Dugo, F.M. Accattatis, A. Granata, L. Arnaboldi, M. Rodolfo, P. Perego, L. Gatti
FoxO-1 contributes to the efficacy of the combination of the XPO1 inhibitor selinexor and cisplatin in ovarian carcinoma preclinical models
2018 C. Corno, S. Stucchi, M. De Cesare, N. Carenini, S. Stamatakos, E. Ciusani, L. Minoli, E. Scanziani, C. Argueta, Y. Landesman, N. Zaffaroni, L. Gatti, P. Perego
Molecular basis for the DNA damage induction and anticancer activity of asymmetrically substituted anthrapyridazone PDZ-7
2017 M. Majus, H. Mateusz, S. Marlena, S. Mazzini, L. Scaglioni, G. Grzegorz J., S. Marcin, L. Jan, S. Marta, W. Joanna, B. Giovanni L., P. Perego, Z. Dominik, B. Maciej, B. Edward, S. Andrzej
Microenvironment-modulated metastatic CD133+/CXCR4+/EpCAM-lung cancer-initiating cells sustain tumor dissemination and correlate with poor prognosis
2015 G. Bertolini, L. D'Amico, M. Moro, E. Landoni, P. Perego, R. Miceli, L. Gatti, F. Andriani, D. Wong, R. Caserini, M. Tortoreto, M. Milione, R. Ferracini, L. Mariani, U. Pastorino, I. Roato, G. Sozzi, L. Roz
Clinicopathological impact of ABCC1/MRP1 and ABCC4/MRP4 in epithelial ovarian carcinoma
2013 M. Bagnoli, G.L. Beretta, L. Gatti, S. Pilotti, P. Alberti, E. Tarantino, M. Barbareschi, S. Canevari, D. Mezzanzanica, P. Perego
Molecular alterations of cells resistant to platinum drugs : role of PKCα
2006 S.C. Righetti, P. Perego, N. Carenini, E. Corna, L. Dal Bo, S. Cedrola, C.A.M. La Porta, F. Zunino
Modulation of pro- and anti-apoptotic factors in human melanoma cells exposed to histone deacetylase inhibitors
2004 F. Facchetti, S. Previdi, M. Ballarini, S. Minucci, P. Perego, C. La Porta